8-KOther Events

Elevance Health, Inc. 8-K Report (Mar 17, 2003)

Filed March 17, 2003For Securities:ELV

Summary

This 8-K filing from Anthem, Inc. (now Elevance Health, Inc.) on March 17, 2003, primarily serves to confirm the company's reiteration of its previously issued earnings expectations for the upcoming analyst and investor meetings. Management anticipates confirming its ability to meet the earnings guidance provided in a February 3, 2003 press release and conference call. This communication is intended to reassure stakeholders that the company is on track to achieve its financial targets. While the filing itself is brief and focuses on the Regulation FD disclosure aspect, it highlights the importance Anthem placed on investor communications and managing expectations. Investors should note that the company also referenced a detailed press release filed on February 4, 2003, as Exhibit 99 to a prior 8-K, which contains forward-looking statements and a comprehensive list of risks and uncertainties. These include factors like healthcare cost trends, regulatory changes, competition, acquisition integration (specifically Trigon Healthcare, Inc.), and general economic conditions.

Key Highlights

  • 1Anthem, Inc. (ELV) is reaffirming its previously issued earnings expectations.
  • 2Company officers will meet with securities analysts and investors during the weeks of March 17 and March 24, 2003.
  • 3Management expects to confirm their ability to meet earnings expectations set on February 3, 2003.
  • 4The filing refers to a press release from February 3, 2003, filed as Exhibit 99 to a prior 8-K.
  • 5The filing includes standard safe harbor language for forward-looking statements.
  • 6Key risks mentioned include healthcare cost trends, regulatory changes, competition, and integration of the Trigon Healthcare acquisition.

Frequently Asked Questions

The primary purpose of this 8-K filing is to disclose that Anthem, Inc. officers will be meeting with securities analysts and investors and expect to confirm the company's ability to meet the earnings expectations previously provided on February 3, 2003. It's a regulatory communication to ensure fair disclosure of material information.

Anthem last communicated its earnings expectations in a press release and conference call on February 3, 2003. A copy of that press release was filed as Exhibit 99 to a previous 8-K filing on February 4, 2003.

The filing references risks and uncertainties that could cause actual results to differ materially from forward-looking statements. These include trends in health care costs and utilization, the ability to secure premium rate increases, competitor pricing, increased government regulation, potential for significant acquisitions or divestitures, new prescription drugs and technology, financial strength rating downgrades, debt levels, litigation, successful integration of the Trigon Healthcare acquisition, and general economic downturns.

No, this 8-K filing does not introduce new financial data. Its purpose is to confirm the company's confidence in meeting previously stated earnings expectations and to provide legally required disclosures regarding forward-looking statements and associated risks.